Israeli Defense Ministry spokesperson reported that researchers at the Israel Institute for Biological Research identified two antiviral drugs as an effective treatment for COVID-19.
– One, an FDA-approved drug and the second, already in the advanced stages of the approval process.
By Arutz Sheva Staff
As part of the wide-ranging efforts of the Israel Institute for Biological Research to identify antiviral drugs for COVID-19, scientists have tested an analogue of the FDA-approved Cerdelga drug, and an analogue of a second drug that is currently in advanced stages of the approval process, an Israeli Defense Ministry spokesperson said Tuesday.
Treatment of a new disease such as COVID-19 using an existing, approved drug may serve as an effective short-term solution considering that one of the major challenges in addressing such a pandemic is the length of time it takes for both the research and approval phases of new drugs. Continue Reading »
With the U.S. Food and Drug Administration’s approval for phase two trials, researchers are hoping that the Israeli drug Aviptadil, will be able to eliminate the so-called Acute Respiratory Distress Syndrome (ARDS), the condition responsible for the deaths of about 50% of all COVID-19 patients.
The U.S. Food and Drug Administration on Sunday has cleared NeuroRx, a US-Israeli pharmaceutical company, and Relief Therapeutics, a Swiss drug development company, for phase two trials for a drug that could take on a deadly condition associated with COVID-19.
The two companies announced that the FDA issued a “study may proceed” letter — which does not amount to a full-fledged drug approval — for the substance to be tried on COVID-19 patients. Continue Reading »
Jerusalem-based Betalin Therapeutics, that includes two Nobel laureates in chemistry, announce they may have found ‘the cure’ with their CEO, Dr. Nikolai Kunicher saying, “The patient should never have to inject insulin into his body again.”
By MAAYAN JAFFE-HOFFMAN
A team of Jerusalem-based researchers and entrepreneurs claim they have a cure for diabetes that could hit the market as early as within the next few years.
Betalin Therapeutics has developed the first bio-artificial pancreas, composed of pig’s lung tissue and insulin secreting cells. The artificial pancreas would be implanted into the patient and connect with his or her blood vessels and then be able to measure the body’s sugar level and secrete an optimal amount of insulin needed to balance blood sugar. Continue Reading »
Headquartered in Herzliya, the Israeli pharmaceutical received the go-ahead from the FDA to commence advanced trials in the U.S. on its long-lasting pain-killer, confidant it will replace the commonly used and highly addictive opiate-based medicines.
JERUSALEM – Israeli pharmaceuticals company PainReform has received approval from the US Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.
Many patients today dealing with pain after surgery are prescribed opioids, which can be highly addictive and are at the heart of a costly health crisis in the United States. Continue Reading »
With Israeli authorities expediting the recognition of French medical credentials that make the transition easier for seasoned professionals, the upsurge in antisemitism in France is convincing their doctors & medical field associates, many of whom hold prestigious and influential leadership positions, to pack-up and leave France with their families for Israel, in increasing numbers.
By BERNARD EDINGER
Michel Alimi says he was shopping at the Hyper Cacher kosher supermarket just a couple of hours before an Islamist struck on January 9, 2015, shooting four Jews dead and holding 16 hostage before being killed by French police. Now, he, his wife and one of his daughters are moving to Israel. Continue Reading »
The London-based institute’s comparative study, examining three basic components of health: availability of preventive care, health infrastructure, and citizens’ physical & mental health, showed Israelis enjoy top health care.
By Chana Roberts
A recent study ranked Israel’s health care system as the ninth-best in the world, the UK’s Business Insider reported.
The research, conducted by the London-based Legatum Institute, compared 104 variables and listed nine subindexes. The study examined three basic components of health: availability of preventive care, health infrastructure, and citizens’ physical and mental health.
Western Galilee Medical Center in Nahariya – Photo courtesy
149 countries were included in the comparison, with Israel included in the top ten. Continue Reading »
Neuroderm, the Israeli pharmaceutical company that deals with “next-generation treatments” was just bought for $1.1B in cash by Mitsubishi Tanabe Pharma
Israeli pharmaceutical company Neuroderm has been bought out in a massive deal for $1.1 billion by Japan’s Mitsubishi Tanabe Pharma Corp, the company announced on Monday.
The all-cash deal will expand the company’s business overseas, according to Reuters.
Medical student conducting research – Photo: Tel Aviv University’s Sackler School of Medicine
NeuroDerm develops drugs and medical devices for central nervous system (CNS) disorders such as Parkinson’s, in which it was the first to develop a key treatment currently used for the disease. Continue Reading »
The manufacture of smokeless, accurately dosed cannabis medication, “with an equal THC – CBD ratio,” is now being produced to treat a wide variety of illnesses, according to the 2 partners’ ‘joint’ statement (no pun intended).
By SHARON UDASIN
An Israeli and New Mexican company have joined forces to launch the first-ever pharmaceutical cannabis production lab in the United States.
The Lod-based Panaxia Pharmaceutical Industries Ltd. and the Albuquerque, New Mexico-based Ultra Health have opened a facility in Bernalillo, New Mexico, that will manufacture smokeless, accurately dosed cannabis medication in a variety of delivery methods, the companies announced this week in a joint statement. Continue Reading »
Hospitals throughout Israel saved 504 lives in 2016 attributed to organ transplants, compared with 433 in 2015.
• 1,116 patients still waiting for organ transplants, most of them needing a liver, kidney or heart.
• 61% of families approached about donating a dead loved one’s organs agreed.
By Maytal Yasur Beit-Or
A record 504 organ transplants were performed in Israel in 2016, a significant increase from the 433 in 2015, according to data from the National Transplant Center. The transplanted organs were taken from both the deceased and the living, giving new life and hope to terminally ill patients. Continue Reading »
Zion Pharmaceutical, founded 30 months ago to manufacture the AIDS and cancer treatment drugs developed by Prof. Abraham Loyter of the Hebrew University of Jerusalem, is seeking the finances to enter the market.
By Gali Weinreb of the Globes
Last week, a new HIV treatment hit the headlines, after it had been tested in the blood of ten patients and found effective in the destruction of cells infected with AIDS – without damaging healthy cells. The drug was developed by Prof. Abraham Loyter from the Hebrew University, and the technology has been commercialized through a company called Zion Pharmaceutical by Yissum, the Hebrew University’s technology commercialization company. Continue Reading »
Tel Aviv University researchers have discovered an “extremely effective way” to prevent the spread of breast cancer to other parts of the body in mice by combining gene therapy with chemotherapy and delivering it to the tumor.
By combining gene therapy with chemotherapy and delivering it to a primary tumor site, researchers at Tel Aviv University’s Sackler Faculty of Medicine have discovered in mice an “extremely effective way” to prevent the spread of breast cancer to other parts of the body.Doctor [Illustrative] – Photo: INGIMAGE
One in eight women worldwide contract breast cancer, making it the second leading cause of cancer death in women. Continue Reading »
Prof. Avigdor Scherz & Prof. Yoram Salomon of the Weizmann Institute develop a groundbreaking treatment for prostate cancer patients that targets the tumor without damaging genitalia, urinary tract, or general quality of life.
By Rotem Elizera
The incidence of prostate cancer, especially among men, in Israel has increased in the past two decades. However, Professor Avigdor Scherz and Professor Yoram Salomon of the Weizmann Institute have developed a groundbreaking treatment, bearing good news for the patients diagnosed with the deadly disease.
Special prostate cancer treatment. – Photo: Yariv Katz
Prostate cancer patients face a dilemma today: Undergoing prostate surgery and radiation, which often causes erectile dysfunction and urinary retention, or staying under “active surveillance,” which could allow the cancer to metastasize. Continue Reading »
Innovative Israeli cure shows 94% of leukemia patients in clinical test in the U.S. exhibits signs of recovery.
By Israel Today Staff
An innovative Israeli-developed cure for leukemia that is currently being tested in the US is seeing amazing results.
The clinical tests have been run primarily on patients with advanced leukemia that were given only a matter of months to live. An astonishing 94 percent have reportedly shown improvement, and in more than half symptoms related to the cancer have disappeared all together.
Professor Zelig Eshhar
Professor Stanley Riddell of the University of Washington, who is running the tests, cautioned that much work remains to clarify the results of the study, and it is still unknown if the treatment managed to remove the cancer completely, or if it will return in the aforementioned patients. Continue Reading »
WoundClot’s unique chemical structure allows the absorption of large amounts of liquids without disintegration while enhancing the blood’s natural process of clotting to stop the bleeding.
A new Israeli-developed bandage aims to save lives in cases of severe bleedings, where conventional treatment procedures could fail to stop a deadly hemorrhage.
According to Yuval Yaskil, owner and CEO of developers Core Scientific Creations (CSC), the bandage, called WoundClot, not only stops severe bleedings within minutes – without the need to apply pressure on the wound – but also enhances the blood’s natural process of clotting. Continue Reading »
Seeking to treat the root of several aging-related diseases, the new clinical trial is testing whether medication can delay onset of certain illnesses, such as cancer, heart disease, and cognitive impairment.
By Liat Levy
The cultural fixation with youth has permeated industries from cosmetics, pharmaceuticals, food, supplements and more. We are frequently hearing that a magical cure is just around the corner.
Dr. Nir Barzilai
Professor Nir Barzilai, director and founder of the Institute for Aging Research at Yeshiva University’s Albert Einstein College of Medicine, has more reason than most to believe that this is not far from the truth. Continue Reading »